<html><head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" /><meta http-equiv="Content-Style-Type" content="text/css" /><meta name="generator" content="Aspose.Words for .NET 13.4.0.0" /><title></title></head><body><div><p style="margin:0pt; text-align:center"><span style="font-family:'Times New Roman'; font-size:12pt">&#xa0;</span></p><p style="margin:0pt; text-align:center"><span style="font-family:'Times New Roman'; font-size:12pt">&#xa0;</span></p><p style="margin:0pt 0pt 6pt; text-align:center"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:bold">Written evidence </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:bold">from the British Society for Rheumatology</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:bold"> (LTC 88)</span></p><p style="margin:0pt 0pt 6pt"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">The British Society for Rheumatology (BSR)</span><a name="_ftnref1"></a><a href="#_ftn1">[1]</a><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> exists to promote excellence in the treatment of people with arthritis and musculoskeletal conditions and to support those delivering it.</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">As a professional association representing those </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">specialising</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> in </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">rheumatic and </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">musculoskeletal conditions, BSR aims to improve standards of care in rheumatology. </span></p><p style="margin:0pt"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">The BSR welcomes the opportunity to contribute to thi</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">s timely</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">, necessary</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> and important inquiry.</span></p><p style="margin:0pt"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">&#xa0;</span></p><p style="margin:0pt"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">Key Points:</span></p><ul type="disc" style="margin:0pt; padding-left:0pt"><li style="font-family:Symbol; font-size:11pt; margin:0pt 0pt 0pt 28.06pt; padding-left:7.94pt; text-indent:0pt"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">Rheumatic diseases are a common, yet under-recognised cause of preventable long-term health impacts and disability ages in the UK.</span></li><li style="font-family:Symbol; font-size:11pt; margin:0pt 0pt 0pt 28.06pt; padding-left:7.94pt; text-indent:0pt"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">Early treatment and service coordination across all health and care sectors offers potential to improve patient experience, improve clinical outcomes, and make significant cost savings.</span></li><li style="font-family:Symbol; font-size:11pt; margin:0pt 0pt 0pt 28.06pt; padding-left:7.94pt; text-indent:0pt"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">There are major variations in rheumatology service provision throughout the UK and compared internationally; however we can highlight best practice approaches that are proving successful.</span></li></ul><p style="margin:0pt"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">&#xa0;</span></p><p style="margin:0pt 0pt 6pt"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:bold">The impact of rheumatic disease</span></p><p style="margin:0pt; text-indent:0pt"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:normal">1.</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:bold">Rheumatology is a multidisciplinary branch of medicine that deals with the investigation, diagnosis and management of patients with rheumatic diseases and other musculoskeletal conditions.</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> This incorporates over 200 disorders affecting joints, muscles and soft tissues, including autoimmune disorders and spinal pain. A significant number of rheumatic conditions also affect other organ systems</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">. </span><br /><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">&#xa0;</span></p><p style="margin:0pt; text-indent:0pt"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:normal">2.</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:bold">Rheumatic diseases are</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:bold"> often</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:bold"> under-prioritise</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:bold">d,</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> in part due to low levels of </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">public </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">awareness about</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> what rheumatology is</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">.</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">A recent survey</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> conducted by the </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">American</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> C</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">ollege of Rheumatology indicated</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">that the word ‘Rheumatology’ is for the majority of public participants not known</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">. For others it was commonly associated with</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> foot doctors/podiatry</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">, or viewed solely as an issue relating to old age</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">.</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> In the UK, the low profile of rheumatology is reflected in the fact that it is only mentioned once in the Department of Health</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">’s Long Term Conditions C</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">ompendium</span><a name="_ftnref2"></a><a href="#_ftn2">[2]</a><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">.</span><br /><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">&#xa0;</span></p><p style="margin:0pt; text-indent:0pt"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:normal">3.</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:bold">Despite</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:bold"> low awareness, m</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:bold">usculoskeletal conditions </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:bold">are the</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:bold"> the single biggest cause of disability</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:bold">,</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> accounting for 31% of the total </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">UK</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> burden</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">. I</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">n contrast </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">to </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">encouraging </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">improvement</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> trends for </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">premature mortality</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">, the </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">UK</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> trend for </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">chronic </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">disability burden is getting worse. </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">I</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">n a rece</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">nt international comparison of </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">disability adjusted life years in </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">developed countries with similar economies, the UK </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">ranks a mere 16</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> out of 19 for </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">osteoarthritis, and 15 out of 19 for low back pain</span><a name="_ftnref3"></a><a href="#_ftn3">[3]</a><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">. C</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">oupled w</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">ith the </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">known health service </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">challenge</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> of an a</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">geing population</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">, it is therefore vital to reverse the trend of avoidable disability through the quality improvement of rheumatology services</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">.</span><br /><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">&#xa0;</span></p><p style="margin:0pt; text-indent:0pt"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:normal">4.</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:bold">A key issue to address is the collection of data, which has </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:bold">failed to evolve</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:bold"> over time</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:bold"> to take account of the t</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:bold">ransformation in</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:bold"> </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:bold">rheumatology treatment</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:bold"> options.</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> Patients with rheumatic disease </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">used to </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">occupy</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> a great number of</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> hospital </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">beds;</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> however</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> drug therapy now allows the provision to be largely ambulatory</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">. </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">Commissioners therefore have little to inform </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">their service specifications, and</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> there is insufficient</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> public health epidemiology data </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">to inform Joint Strategic Needs Assessments.</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">The fact there are over 200 conditions can</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> further</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> hinder understanding and therefore the BSR has created a simpler domain and pathway app</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">roach. </span><br /><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">&#xa0;</span></p><p style="margin:0pt; text-indent:0pt"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:normal">5.</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">Although rheumatology services </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">no longer</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">services are no longer mainly inpatient rehabilitation services</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> involving</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> hospital</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> admission, the p</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">otential </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">for </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:bold">Quality, Innovation, Productivity and Prevention (</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:bold">QIPP</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:bold">)</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:bold"> savings</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:bold"> </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:bold">remain</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:bold"> significant</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:bold">, as </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:bold">£680m was spent on drug therapy in England alone in 2012</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:bold">.</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:bold"> </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">S</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">avings come from treating people to NICE and national standards and early diagnosis and intervention, and include</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">:</span></p><ol type="a" style="margin:0pt; padding-left:0pt"><ol type="a" style="margin:0pt; padding-left:0pt"><li style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; margin:0pt 0pt 0pt 66.63pt; padding-left:5.37pt; text-indent:0pt"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">reduction in the need to use expensive biologics</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> for advancing</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> disease,</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> </span></li><li style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; margin:0pt 0pt 0pt 67.25pt; padding-left:4.75pt; text-indent:0pt"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">reduced need for</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> joint replacements, </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">as </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">combined cost of hospital and social care for patients with a hip fracture amounts to more than £2.3billion per year in the UK</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">,</span></li><li style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; margin:0pt 0pt 0pt 66.63pt; padding-left:5.37pt; text-indent:0pt"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">reduced </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">health and social care </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">costs (including nursing home requirements) for</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">disability </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">caused by</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> high disease activity</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">, </span></li><li style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; margin:0pt 0pt 0pt 67.25pt; padding-left:4.75pt; text-indent:0pt"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">and reduction in the percentage of</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> all</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> patients </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">(currently a third) </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">unable to</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> work within two</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> years of diagnosis</span><a name="_ftnref4"></a><a href="#_ftn4">[4]</a><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">.</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">The Health and Safety Executive estimated in 2011 that over nine million working days are lost each year from work-related musculoskeletal disorders. </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:bold">The estimated </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:bold">cost to the economy of sick leave and work-related disability for people with rheumatoid arthritis is £1.8 billion a year.</span><br /><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">&#xa0;</span></li></ol></ol><p style="margin:0pt 0pt 6pt; text-indent:0pt"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:normal">6.</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:bold">Below we outline some examples </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:bold">in which</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:bold"> </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:bold">rheumatology </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:bold">services have been configured to offer the patient benefits and reduced costs</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> outlined above.</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">However service provision remains varied throughout the </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">UK; the challenge is therefore to enable the delivery of consistently excellent services.</span></p><p style="margin:0pt 0pt 6pt"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:bold">Early intervention and </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:bold">the </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:bold">integrated care</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:bold"> patient pathway</span></p><p style="margin:0pt; text-indent:0pt"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:normal">7.</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">Unlike other services which can be wholly community-based, effective </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:bold">rheumatology services require </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:bold">integrated care along the whole patient pathway</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:bold">,</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:bold"> </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:bold">across secondary, </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:bold">community and primary ca</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:bold">re</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">. This is </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">due to</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">the </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">diag</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">nostic</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">infrastructure required, and the complexity of autoimmune diseases which can affect multiple organ systems</span><a name="_ftnref5"></a><a href="#_ftn5">[5]</a><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">.</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> </span></p><p style="margin:0pt"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">&#xa0;</span></p><p style="margin:0pt; text-indent:0pt"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:normal">8.</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">Wherever rheumatology services are delivered</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">,</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> there needs to be </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">an </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:bold">extensive</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:bold">diagnostics infrastructure in place</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> incorporating MRI, ultrasound/X-ray and complex blood testing</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">.</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">Unless there is a major investment in community diagnostic centres, </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">this will continue to be provided in acute or community hospital settings.</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">The benefit of having these diagnostic tools in a ‘one-stop shop’ is that the patient avoids the inconve</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">nience of multiple appointments </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">(and</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> associated multiple costs</span><a name="_GoBack"></a><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">) and</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> the crucial time period from symptom onset to treatment is minimised. </span></p><p style="margin:0pt"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">&#xa0;</span></p><p style="margin:0pt; text-indent:0pt"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:normal">9.</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:bold">Early intervention</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:bold"> is </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:bold">clinically</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:bold"> significant in rheumatology. Up to three months after symptom onset, rheumatic diseases can be treated effectively</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:bold"> (to a low level or remission)</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:bold"> with relatively inexpensive disease-modifying </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:bold">antirheumatic </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:bold">drugs (DMARDS). </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">A treatment delay of more than three months can result in a more aggressive course to the disease which </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">causes long term damage to joints, and</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> require</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">s</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> expensive biologic treatments.</span></p><p style="margin:0pt"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">&#xa0;</span></p><p style="margin:0pt; text-indent:0pt"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:normal">10.</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">Although the NICE guideline requires that</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> patie</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">nts are put onto DMARDs within three</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> months of symptom onset</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">, a </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">NAO report in 2009 </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">found that this happens with only 10% of patients</span><a name="_ftnref6"></a><a href="#_ftn6">[6]</a><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">.</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> This is in part due to delays in being seen by a rheumatologist and partly due to local differences in the access level to key drugs.</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> The average delay in the UK in GP surgeries is around nine months, by which time joint damage in aggressive disease has already occurred.</span></p><p style="margin:0pt 0pt 0pt 36pt"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">&#xa0;</span></p><p style="margin:0pt; text-indent:0pt"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:normal">11.</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">The same report concluded that</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> o</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">nly 63% of patients in acute trusts provided annual review for Rheumatoid Arthritis patients to monitor disease progression a</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">nd emergence of co-morbidities.</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> This indicates that </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:bold">there is some way to go in integrating </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:bold">care</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:bold"> for ongoing management of patients with rheumatic disease, as well as initial diagnosis and treatment</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">.</span></p><p style="margin:0pt 0pt 0pt 36pt"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">&#xa0;</span></p><p style="margin:0pt 0pt 6pt; text-indent:0pt"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:normal">12.</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">The significance of this is </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">shown</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> in a recent National Rheumatoid Arthritis Society</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> (NRAS)</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> recently report</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:7.33pt; vertical-align:super">5</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> that highlights the range and impact of comorbidities associated with rheumatoid arthritis, and demonstrates the extent to which rheumatology services </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">need to</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> be linked to other specialist and community services in a coordinated and holistic manner. Key points from this report include the following:</span></p><ol type="a" style="margin:0pt; padding-left:0pt"><ol type="a" style="margin:0pt; padding-left:0pt"><li style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:bold; margin:0pt 0pt 6pt 67.25pt; padding-left:4.75pt; text-indent:0pt"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:bold">Around 80 per cent of rheumatoid arthritis (RA) patients will have one or more co-morbidities. </span></li><li style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; margin:0pt 0pt 6pt 67.25pt; padding-left:4.75pt; text-indent:0pt"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">The risk of heart attack is doubled for RA patients. The risk of atrial fibrillation is around 40 per cent higher among RA patients than those without RA. The risk of stroke is 30 per cent higher for RA patients. </span></li><li style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; margin:0pt 0pt 6pt 66.63pt; padding-left:5.37pt; text-indent:0pt"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">Interstitial lung disease associated with RA is a major cause of death amongst RA patients. </span></li><li style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; margin:0pt 0pt 6pt 67.25pt; padding-left:4.75pt; text-indent:0pt"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">Rates of osteoporosis can be up to twice as high amongst RA patients than the general population. </span></li></ol></ol><p style="margin:0pt 0pt 6pt; text-indent:0pt"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:normal">13.</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">Most</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> financial incentives for good practice in </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">the current system</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> only focus on parts of the pathway – </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">discreet</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> pieces of care as opposed to the whole </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">patient care package</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">. </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">This approach is a key system barrier to the principle of integrated care.</span></p><p style="margin:0pt 0pt 6pt"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:bold">Commissioner support, and best practice examples</span></p><p style="margin:0pt; text-indent:0pt"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:normal">14.</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">The BSR</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> have joined</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> with Arthritis Care and </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">NRAS</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">to </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">form the Rheumatology Commissioning Support </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">Alliance – a project funded by the </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">Department of Health</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> to </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">support commissioners and develop tools to demonstrate how better services for patients and better value for the NHS can both result from a more service-user-centred approach.</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> </span></p><p style="margin:0pt"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">&#xa0;</span></p><p style="margin:0pt; text-indent:0pt"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:normal">15.</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">The BSR has also recently launched a Commissioning Toolkit for Providers</span><a name="_ftnref7"></a><a href="#_ftn7">[7]</a><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">. This package aims to help rheumatology professionals develop their knowledge and skills to design effective services and make the most of commissioning opportunities.</span></p><p style="margin:0pt"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">&#xa0;</span></p><p style="margin:0pt; text-indent:0pt"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:normal">16.</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">In addition to the initiatives above, </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:bold">the BSR is proactively developing a hub </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:bold">of good practice service models</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">. We intend to publish case studies in the </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">autumn</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">, however in advance of this we outline two models</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> below</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> that give a flavour of current initia</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">tives being delivered in the UK</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">.</span><br /><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">&#xa0;</span></p><p style="margin:0pt 0pt 6pt; text-indent:0pt"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:normal">17.</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">Site A example</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> :</span></p><ol type="a" style="margin:0pt; padding-left:0pt"><ol type="a" style="margin:0pt; padding-left:0pt"><li style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; margin:0pt 0pt 6pt 66.63pt; padding-left:5.37pt; text-indent:0pt"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">Standardised whole patient pathway </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">that meets</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> all NICE and European standards</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">.</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> </span></li><li style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; margin:0pt 0pt 6pt 67.25pt; padding-left:4.75pt; text-indent:0pt"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">Single set of patient records between </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">doctors</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> and</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> the</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">multi-disciplinary team (MDT)</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">.</span></li><li style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; margin:0pt 0pt 6pt 66.63pt; padding-left:5.37pt; text-indent:0pt"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">Hand-held patient records</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> for decision making</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> </span></li><li style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; margin:0pt 0pt 6pt 67.25pt; padding-left:4.75pt; text-indent:0pt"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">Early cognitive behavioural therapy regarding first-stage disease perception</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">.</span></li><li style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; margin:0pt 0pt 6pt 66.63pt; padding-left:5.37pt; text-indent:0pt"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">The first eight</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> weeks of drug therapy are prescribed</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> by GPs after diagnosis – primar</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">y care is the first part of the pathway with an agreed protocol</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">.</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> </span></li><li style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; margin:0pt 0pt 6pt 65.41pt; padding-left:6.59pt; text-indent:0pt"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">The patient is a partner in treatment and </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">goes to a</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">ll meetings including research</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">.</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> </span></li><li style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; margin:0pt 0pt 6pt 67.25pt; padding-left:4.75pt; text-indent:0pt"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">There is a s</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">pecialist nurse</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> car</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">e co-ordinator across acute</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">,</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> community and primary care. This includes a hot line and direct access for GPs and patients, </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">enabling </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">self-care</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">,</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> helping people stay in the community</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> and enabling</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> rapid response to disease flares.</span></li></ol></ol><p style="margin:0pt; text-indent:0pt"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:normal">18.</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:bold">Site A outcome: reduced work loss due to depression and anxiety</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:bold">,</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:bold"> and </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:bold">40% reduction in the</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:bold"> need to </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:bold">use</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:bold"> expensive biologic</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:bold"> drugs.</span></p><p style="margin:0pt"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">&#xa0;</span></p><p style="margin:0pt 0pt 6pt; text-indent:0pt"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:normal">19.</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">Site B</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> example:</span></p><ol type="a" style="margin:0pt; padding-left:0pt"><ol type="a" style="margin:0pt; padding-left:0pt"><li style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; margin:0pt 0pt 6pt 66.63pt; padding-left:5.37pt; text-indent:0pt"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">Working with community pharmacy to reduce medicine</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> costs incurred through w</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">astage an</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">d expiry.</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> </span></li><li style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; margin:0pt 0pt 6pt 67.25pt; padding-left:4.75pt; text-indent:0pt"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">A ‘treat</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> to target</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">’ biologics approach (personalised prescribing b</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">ased on individual patient data as opposed to standard drug and dosage regimes).</span></li><li style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; margin:0pt 0pt 6pt 66.63pt; padding-left:5.37pt; text-indent:0pt"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">Patient partner training </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">for over</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> 2000 GPs to enable better referral. </span></li><li style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; margin:0pt 0pt 6pt 67.25pt; padding-left:4.75pt; text-indent:0pt"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">There is a specialist nurse care co-ordinator across acute, community and primary care. This includes a hot line and direct access for GPs and patients, enabling self-care, helping people stay in the community and enabling rapid response to disease flares.</span></li></ol></ol><p style="margin:0pt; text-indent:0pt"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:normal">20.</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:bold">Site B outcome: Savings of over a quarter of a million pounds per year over the last three years. These are shared between </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:bold">the </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:bold">commissioner and provider.</span></p><p style="margin:0pt"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:bold">&#xa0;</span></p><p style="margin:0pt 0pt 6pt; text-indent:0pt"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:normal">21.</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">The BSR is happy to</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:bold"> </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">expand further on any of the points raised in this submission.</span></p><p style="margin:0pt 0pt 6pt"><br /><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-style:italic">May 2013</span></p></div><hr style="width:33%; height:1px; text-align:left" /><p style="margin:0pt"><a name="_ftn1"></a><a href="#_ftnref1">[1]</a><span style="font-family:'Frutiger LT Std 45 Light'; font-size:9pt"> BSR website: http://www.rheumatology.org.uk/</span></p><p style="margin:0pt"><a name="_ftn2"></a><a href="#_ftnref2">[2]</a><span style="font-family:'Frutiger LT Std 45 Light'; font-size:9pt"> Third Edition Long Term Conditions Compendium, Department of Health (May 2012): https://www.gov.uk/government/news/third-edition-of-long-term-conditions-compendium-published</span></p><p style="margin:0pt"><a name="_ftn3"></a><a href="#_ftnref3">[3]</a><span style="font-family:'Frutiger LT Std 45 Light'; font-size:9pt"> UK health performance: findings of the Global Burden of Disease study 2010: http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(13)60355-4/abstract</span></p><p style="margin:0pt"><a name="_ftn4"></a><a href="#_ftnref4">[4]</a><span style="font-family:'Frutiger LT Std 45 Light'; font-size:9pt">NICE guideline for rheumatoid arthritis: http://publications.nice.org.uk/rheumatoid-arthritis-cg79</span></p><p style="margin:0pt"><a name="_ftn5"></a><a href="#_ftnref5">[5]</a><span style="font-family:'Frutiger LT Std 45 Light'; font-size:9pt"> NRAS ‘The Impact of Rheumatoid Arthritis Co-morbidities’ December 2012: http://www.nras.org.uk/includes/documents/cm_docs/2012/t/1_the_impact_of_rheumatoid_arthritis_comorbidities_final_pdf_pdf.pdf</span></p><p style="margin:0pt"><a name="_ftn6"></a><a href="#_ftnref6">[6]</a><span style="font-family:'Frutiger LT Std 45 Light'; font-size:9pt"> NAO rheumatoid arthritis report 2009: http://www.nao.org.uk/report/services-for-people-with-rheumatoid-arthritis/</span></p><p style="margin:0pt"><a name="_ftn7"></a><a href="#_ftnref7">[7]</a><span style="font-family:'Frutiger LT Std 45 Light'; font-size:9pt"> BSR Commissioning toolkit, March 2013: http://www.rheumatology.org.uk/about_bsr/press_releases/commissioning_toolkit_launched.aspx</span></p></body></html>